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4 regulate, the ABC transporters breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance protein (MRP) 4 (ABCC4) (Ebert et al., 2005; Gelhaus et al., 2012) . The heterocyclic amine 2-amino-1-methyl-6-phenylimidazol [4,5-b] pyridine (PhIP) as well as the heavy metal cadmium interact with BCRP activity (Kummu et al., 2012; van Herwaarden et al., 2003) . Cadmium is moreover transported by the SLC transporters organic cation transporter (OCT) 1 (SLC22A1), OCT2 (SLC22A2), multidrug and toxin extrusion protein (MATE) 1 (SLC47A1) and MATE2-K (SLC47A2) (Soodvilai et al., 2011; Yang et al., 2017) .
Another heavy metal present in cigarette smoke, i.e., arsenic, is handled by the ABC transporters MRP1 (ABCC1) and MRP2 (ABCC2) (Leslie, 2012) and regulates their expression (Takeshita et al., 2003; Vernhet et al., 2001 ).
Interestingly, cigarette smoke condensate (CSC) and cigarette smoke extract as whole mixtures impair activity and/or expression of various ABC and/or SLC transporters (Pan et al., 2009; Sayyed et al., 2016; Takano et al., 2016; van der Deen et al., 2007) . CSC notably blocks activity of hepatic transporters handling anionic drugs such as the canalicular ABC transporter MRP2 and the sinusoidal SLC transporters organic anion transporting polypeptide (OATP) 1B1 (SLCO1B1) and OATP1B3 (SLCO1B3) (Sayyed et al., 2016) . Functional activity of MRP1, which handles drugs conjugated to anionic ligands (Cole and Deeley, 2006) , has also been shown to be altered in lung epithelial cells exposed to cigarette smoke extract (van der Deen et al., 2007) . Whether CSC may additionally block other SLC drug transporters handling anionic drugs, such as organic anion transporter (OAT) 1 (SLC22A6) and OAT3 (SLC22A8), remains however unknown. This issue is likely important to consider because OAT1 and OAT3, notably located at the basolateral pole of proximal tubule cells and acting as dicarboxylate exchangers, play a major role in tubular secretion of drugs, and by this way, in their renal elimination and pharmacokinetics (Burckhardt, 2012) . OAT1 and OAT3 are consequently identified as drug transporters that have to be studied during the
5 pharmaceutical development of new molecular entities according to a regulatory point of view, notably because inhibition of these transporters can be the cause of drug-drug interactions (DDI) (Giacomini et al., 2010; Maeda and Sugiyama, 2013) . The present study was therefore designed to analyze the effects of CSC and various cigarette smoke-contained chemicals on activity of these OATs.
Materials and Methods

Chemicals
CSC was supplied by Murty Pharmaceuticals (Lexington, KY, USA). It was prepared by smoking University of Kentucky's 3R4F standard research cigarettes on a Federal Trade Commission smoke machine (Nagaraj et al., 2006) . The amount of smoke particulates, collected on a glass fiber filter, was determined by weight increase of the filter. It corresponds to a mean of 9.5 mg total particular matter/cigarette (Eldridge et al., 2015) . CSC was finally prepared by dissolving the collected smoke particulates in dimethyl sulfoxide (DMSO) to yield a 40 mg/mL solution. Probenecid, amitriptyline, verapamil, 6-carboxyfluorescein, nicotine, benzo(a)pyrene, phenanthrene, 4-aminobiphenyl, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), glutarate, sodium arsenate and lead chloride were provided by Sigma-Aldrich (Saint-Quentin Fallavier, France), whereas cadmium chloride was from Merck
Millipore (Fontenay-sous-Bois, France). The heterocyclic amines PhIP, 2-amino-9H- 
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A C C E P T E D M A N U S C R I P T Technologie Servier (Orléans, France) and characterized in previous studies Chedik et al., 2017) , were cultured in Dulbecco's modified Eagle medium (DMEM) (Life Technologies, Saint Aubin, France) supplemented with 10% (vol/vol) fetal calf serum, 10 IU/mL penicillin, 10 µg/mL streptomycin, 1% nonessential amino acids, and 1 µg/mL insulin. HEK293 cells overexpressing OAT4 (HEK-OAT4 cells) were prepared by transduction of HEK293 cells by lentiviral pLV-EF1-hOAT4-hPGK-GFP vector, as previously described (Jouan et al., 2014) . Construction of the lentiviral vector, production of lentivirus supernatants, transduction of HEK293 cells and cloning and initial characterization of HEK-OAT4 cells were performed by Vectalys (Labège, France). HEK-OAT4 cells were next routinely cultured in DMEM medium as described above.
Transporter activity assays
The effects of CSC and cigarette smoke-contained chemicals on SLC transporter activities were analyzed through determining intracellular accumulation of reference substrates using a well-defined transport medium, as previously reported Sayyed et al., 2016) . The transport assay medium consisted of 5.3 mM KCl, 1.1 mM KH 2 PO 4 , 0.8 mM MgSO 4 , 1.8 mM CaCl 2 , 11 mM D-glucose, 10 mM HEPES, and 136 mM NaCl; pH was adjusted to 7.4 value, except for the pH-sensitive MATE2-K transport assay for which pH was set at 8.4 . Cells were first washed with phosphate-buffered saline and then incubated at 37 °C for 5 min with transport assay buffer containing reference substrates, in the presence or absence of reference transporter inhibitors, CSC or cigarette 
Trans-stimulation assays
Trans-stimulation assays were performed in HEK-OAT1 and HEK-OAT3 cells using the OAT1/OAT3 substrate dicarboxylate glutarate as a reference trans-stimulating agent (Apiwattanakul et al., 1999; Sweet et al., 2003) . Briefly, HEK-OAT1 and HEK-OAT3 cells were first incubated with 1 mM glutarate, 80 or 320 µg/mL CSC or 100 µM cigarette smoke chemical for 15 min at 37°C. After washing with PBS, cells were next re-incubated with the OAT1/OAT3 substrate 6-carboxyfluorescein for 5 min at 37°C in the transport assay medium.
Intracellular accumulation of the fluorescent dye was finally determined as reported above.
Data were expressed as percentages of 6-carboxyfluorescein accumulation found in control cells not exposed to glutarate, CSC or cigarette smoke chemicals.
Chemical combination assays
The combined effects of the heterocyclic amines PhIP and AαC on OAT3 activity were evaluated by median drug effect analysis, as previously described (Chou, 2006) . Briefly, the inhibitory effects of combinations of PhIP and AC towards OAT3-mediated transport were studied as a fixed constant ratio (2:11), chosen according to the IC 50 value of each chemical, using 2-fold serial dilutions with several concentration points below and above IC 50 values of each heterocyclic amine used as a single chemical (Chou, 2010) . Data from combination and single chemical effects towards OAT3 activity were then processed using the CompuSyn software (ComboSyn, Inc., Paramus, NJ, USA), allowing thus to determine combination index (CI) values. The CI is a numerical index that is calculated using the following equation (Zhao et al., 2004 ):
where C PhIP/Mixture and C AC/Mixture are the concentrations of PhIP and AC applied in combination to achieve x % of OAT3 activity inhibition, whereas C PhIP and C AC represent the concentrations of individual agents to accomplish the same efficacy. Combinations were considered as synergistic when CI<0.8, additive when 0.8<CI<1.2 and antagonistic when CI>1.2 (Bijnsdorp et al., 2011) .
Statistical analysis
Quantitative data related to transporter activity inhibition were usually expressed as means ± SEM from at least three independent experiments. They were statistically analyzed through analysis of variance (ANOVA) followed by Dunnett's ost-hoc test using GraphPad
Prism software. The criterion of significance was p < 0.05.
Results
Inhibition of OAT activities by CSC
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The effects of two concentrations of CSC, i.e., 80 and 320 µg/mL, which correspond to non-cytotoxic concentrations similar to those retained in previous studies (Cohen et al., 2009; Sayyed et al., 2016) , were first analyzed in OAT-transfected HEK293 cells. As shown in Fig. 1 , both 80 and 320 µg/mL CSC significantly decreased PAH and E3S accumulation in HEK-OAT1 and HEK-OAT3 cells, respectively. CSC used at 320 µg/mL notably reduced PAH uptake by 80.0 + 2.3 % and that of E3S by 79.4 + 2.1 %. These inhibitory effects of CSC on OAT1 and OAT3 activity were close to those of the reference OAT inhibitor probenecid ( Fig. 1 ). They were concentration-dependent, with CSC IC 50 values lower for OAT3 (27.3 + 1.7 µg/mL) than for OAT1 (72.1 + 1.7 µg/mL) ( Fig. 2 ). As shown in Fig. 1 , CSC used at 320 µg/mL also decreased uptake of E3S in HEK293 cells transfected by OAT4, a renal apical organic/anion exchanger involved in reabsorption of some anionic drugs in proximal tubules (Burckhardt and Burckhardt, 2011; Ekaratanawong et al., 2004) . The lower concentration of 80 µg/mL CSC was however inactive on OAT4-mediated transport of E3S
( Fig. 1 ) and the IC 50 value of CSC towards OAT4 activity was found to be rather high (351.5 + 1.6 µg/mL) ( Fig. 2 ).
We then considered whether in vitro inhibition of OATs by CSC may be relevant in terms of DDI. For this, we applied the criteria retained by the US Food and Drug Administration (FDA) for plasma inhibitor concentration, according to which a potential DDI with respect to a drug inhibiting a transporter can be predicted from in vitro data when the maximum total plasma (bound plus unbound) concentration (C max ) of the investigated drug at steady state ([I]) divided by its in vitro inhibitory potency (IC 50 ) is greater than or equal to 0.1 et al., 2010; Maeda and Sugiyama, 2013) . The maximal total plasma concentration reached by CSC in plasma of smokers, i.e., I CSC , is unfortunately not reported in the literature according to the best of our knowledge. In this context, it is however noteworthy that smoking induces in vivo expression of cytochromes P-450 1A1, 1A2 and 1B1
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11 expression in human tissues, notably in the liver (Chang et al., 2003) . Because such inductions of these drug metabolizing enzymes requires CSC concentrations in the 15-45 µg/mL range in cultured cells (Sayyed et al., 2016) , it can therefore be hypothesized that such a concentration range is reached in vivo for smokers. The higher value of this range of concentrations, i.e., 45 µg/mL, may be retained as I CSC value, with the caution that CSC contains more than 5,000 chemicals that may have, for each of them, specific pharmacokinetics profile. Applying this I CSC for DDI risk assessment indicated that the ratio I CSC /IC 50 is >0.1 for each OAT (Table 1 ).
Potential DDI due to cigarette smoke may concern therefore OAT1, OAT3 and OAT4.
In addition to OAT activities, those of the SLC transporters OCT2 (found at the basolateral pole of proximal tubular cells) and MATE2-K (expressed at the apical pole of proximal tubular cells), implicated in renal tubular secretion of cationic drugs (Motohashi and Inui, 2013), were impacted by CSC. CSC used at 320 µg/mL thus decreased TEA uptake in HEK-OCT2 and HEK-MATE2-K cells (Fig. S1A ). MATE2-K activity was however more sensitive to inhibition by CSC (IC 50 =61.4 + 2.3 µg/mL) than OCT2 activity (IC 50 =226.2 + 3.0 µg/mL) (Fig. S1B ).
Inhibition of OAT1 and OAT3 activities by cigarette smoke-contained chemicals
The effects of some reference cigarette smoke-contained chemicals, including nicotine, 4-aminobiphenyl, the polycyclic aromatic hydrocarbons benzo(a)pyrene and phenanthrene, the nitrosamine NNK, the heterocyclic amines AαC, MeAαC, Trp-P-2 and PhIP and the metals cadmium, lead and arsenic (van Leeuwen et al., 2005) , on OAT1-and OAT3-mediated uptake of the reference OAT substrate 6-carboxyfluorescein were next analyzed. As shown in Fig. 3A , for chemicals used at 100 µM, only the heterocyclic amine
PhIP was found to significantly reduce accumulation of the dye in HEK-OAT1 cells; this decrease was marked (by 92.1 + 0.8 %) and similar to that occurring in response to the
reference OAT inhibitor probenecid. Inhibitory effect of PhIP towards OAT1 activity was next shown to be concentration-dependent (IC 50 =3.3 + 1.3 µM) (Fig. 3B) . With respect to OAT3-mediated uptake of 6-carboxyfluorescein, it was found to be significantly reduced by the heterocyclic amines AC, Trp-P-2 and PhIP, as well as by the reference inhibitor probenecid (Fig. 4A) . The blocking effects of AC and PhIP towards OAT3 activity were concentration-dependent (AC IC 50 =11.3 + 1.3 µM and PhIP IC 50 =1.9 + 0.4 µM) (Fig. 4B ).
PhIP, used at 100 µM, which blocked both OAT1 and OAT3 activity, however failed to hinder OAT4-mediated E3S uptake in HEK-OAT4 cells (Fig. S2) , thus demonstrating that its inhibitory effect towards OAT1 and OAT3 was rather specific. 100 µM Ac also did not inhibit OAT4 activity (Fig. S2) . In contrast to heterocyclic amines, metals were found to cisstimulate OAT3-mediated 6-carboxyfluorescein uptake; cadmium, lead and arsenic thus enhanced dye accumulation by 67.5 + 20.5 %, 75.2 + 15.4 % and 53.8 + 22.0 %, respectively (Fig. 4A) . Nicotine, 4-aminobiphenyl, the nitrosoamine NNK, the polycyclic aromatic hydrocarbons benzo(a)pyrene and phenanthrene and the heterocyclic amine MeAC failed to significantly impair OAT3 activity (Fig. 4A ).
Because CSC is a complex mixture of chemicals, its effect on SLC transporters, notably OAT3, may be hypothesized to reflect the combined effect of chemicals contained in CSC, and not the effect of only a single chemical. In this context, the exact nature of chemical mixture effects, i.e., synergistic, additive or antagonistic, may be important to determine. To get initial information about this point, we characterized the effects of the combination PhIP/AC towards OAT3 activity through calculating CI using the CompuSyn software. As shown in Table 2 , the low concentrations of PhIP/AC (up to 3.02 µM) were found to exert synergistic inhibition towards OAT3-mediated transport (CI<0.8), whereas higher concentrations were mostly additive (0.8<CI<1.2). Only the very high mixture concentration of 153.2 µM exhibited antagonistic effect (CI>1.2) ( Table 2) .
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Finally, we investigated whether PhIP can trans-stimulate 6-carboxyfluorescein uptake in HEK-OAT1 and HEK-OAT3 cells, which may constitute an argument in favor of the transport of the heterocyclic amine by OAT1 and/or OAT3 (Apiwattanakul et al., 1999; Sweet et al., 2003) . Pre-loading with PhIP however resulted in trans-inhibition, and not transstimulation, of dye uptake in both HEK-OAT1 and HEK-OAT3 cells (Fig. 5) . Pre-loading with 80 or 320 µg/mL CSC also led to trans-inhibition of dye uptake (Fig. 5) . AC similarly trans-inhibited 6-carboxyfluorescein accumulation in HEK-OAT1 cells. By contrast, preloading with glutarate resulted in a trans-stimulation of 6-carboxyfluorescein accumulation in HEK-OAT1 and HEK-OAT3 cells (Fig. 5) , as expected for an OAT1/3 substrate like glutarate (Apiwattanakul et al., 1999; Sweet et al., 2003) .
Discussion
CSC and cigarette smoke extract have been recently demonstrated to impair activity and/or expression of various drug transporters in hepatic or pulmonary lung cells (Sayyed et al., 2016; Takano et al., 2016; van der Deen et al., 2007) , thus supporting the idea that drug transporters may constitute general targets of cigarette smoke. The data reported in the present study fully support this hypothesis through demonstrating that CSC can inhibit activity of the anionic drug transporters OAT1, OAT3 and OAT4, mainly expressed at the kidney level.
Renal transporters of cationic drugs such as OCT2 and MATE2-K were additionally affected by CSC. These renal and also other non-renal transporters whose activity is affected by CSC are summarized in The differential sensitivity of OATs to inhibition by CSC, i.e., OAT3 is potently blocked, whereas OAT1 is more moderately inhibited and OAT4 is more marginally affected, discards any general unspecific inhibitory effect of CSC towards OATs and beyond, towards drug transporters. The inhibition of OAT3 activity by CSC therefore likely implicates direct and specific interactions of CSC-contained chemicals with substrate and/or regulatory drug binding sites on the transporter, as classically reported for drug transporter inhibitors (Montanari and Ecker, 2015) . In this context, a role for nicotine, polycyclic aromatic hydrocarbons, NNK and 4-aminobiphenyl is unlikely, owing to the failure of these chemicals to modulate OAT3 activity. An implication of metals such as cadmium, lead and arsenic can also be excluded, because these compounds rather cis-stimulated, and did not inhibit, OAT3 far from those inhibiting OAT3, which are in the 10 µM range (Fig. 4B) , thus discarding any direct contribution of AC to OAT3 inhibition by CSC. A similar conclusion can likely be drawn for putative direct PhIP contribution to OAT3 or OAT1 activity inhibition by CSC, knowing moreover that PhIP is thought to be less abundant than AC in cigarette smoke (Konorev et al., 2015; Manabe et al., 1991) . OAT1 and OAT3 inhibition by CSC may therefore likely implicate chemicals that remain to be characterized. Alternatively, OAT1 and OAT3 inhibition may reflect the combining effects of various chemicals, which may display synergism or additivity. This hypothesis is supported by the fact that the combination of AC/PhIP was demonstrated to exert synergistic inhibition towards OAT3 activity when considering low concentrations of the mixture. Mixture of chemicals, rather than individual ones, may have therefore to be considered when addressing effects of environmental contaminants, including putative inhibitory effects towards transporters. In agreement with this conclusion, a realistic combination of marine pollutants as well as binary mixtures of pesticides have been demonstrated to block P-glycoprotein activity (Nicklisch et al., 2016; Pivcevic and Zaja, 2006) .
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In addition to OAT1 and OAT3, various ABC efflux pumps interact with heterocyclic amines. Indeed, BCRP transports PhIP, and by this way, restricts human exposure to this carcinogen through decreasing its uptake from the gut lumen and mediating its hepatobiliary and intestinal elimination (van Herwaarden et al., 2003) . MRP2, MRP3 and P-glycoprotein have also been shown to handle PhIP and its genotoxic metabolites (Vlaming et al., 2014 The in vivo relevance of OAT1/OAT3 inhibition by CSC and the possible consequences in terms of cigarette smoke toxicity or drug pharmacokinetics for smokers remains to be determined. It is nevertheless noteworthy that DDI risk assessment, performed according to FDA criteria and with a putative theoretical value of 45 µg/mL for maximal plasma CSC concentration, indicated that potential DDI due to cigarette smoke may concern OAT1, OAT3 and OAT4. OAT3, which is the most sensitive OAT to inhibitory effects of CSC, is likely the first one to be considered in this context of DDI caused by smoking, which, besides, is known to impair renal functions (Cooper, 2006; Orth, 2002) . Renal secretion of drugs handled by OAT3, such as, for example, the antibiotics benzylpenicillin and cephaloridine, the anticancer drug methotrexate and lipids-lowering statins (Burckhardt, 2012) , may consequently be compromised in smokers. Further studies are likely required to validate or not this hypothesis, knowing moreover that many substrates of OAT3 are shared
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17 with OAT1 (Nigam et al., 2015a) , which is less sensitive to inhibition by CSC and which may therefore compensate putative renal OAT3 inhibition in smokers. Importantly, besides drugs, various endogenous hormones, nutrients and metabolites are substrates for OAT3 (Nigam et al., 2015b) . Data from Oat3-knock-out mice have additionally revealed a role for the transporter in several metabolic pathways, including the tricarboxylic acid cycle, nucleotide and amino acid metabolism, prostaglandin and steroid metabolism, as well as the metabolism of dietary flavonoids (Wu et al., 2013) . Transport of endogenous OAT3 substrates as well as OAT3-related physiological ways may therefore be affected by OAT3 inhibition due to smoking, which may contribute to the pleomorphic toxicity of cigarette smoke. Finally, because OAT3 is also expressed at the choroid plexus, the brain capillary endothelium, and retina (Miyajima et al., 2011; Urquhart and Kim, 2009) , putative consequences of its inhibition at these extra-renal sites may also deserve attention for smokers.
In summary, CSC and some cigarette smoke-contained chemicals like the heterocyclic amine PhIP were shown to in vitro inhibit OATs, notably OAT3. Such an inhibition of OAT3 activity may contribute to alterations of pharmacokinetics or some adverse toxic effects caused by smoking. 
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